Medpace(US:MEDP) ZACKSยท2025-10-16 23:16Company Performance - Medpace (MEDP) closed at $521.21, reflecting a +1.34% increase from the previous day, outperforming the S&P 500's decline of 0.63% [1] - Over the past month, Medpace shares have risen by 3.31%, surpassing the Medical sector's gain of 3.09% and the S&P 500's gain of 0.92% [1] Upcoming Earnings - Medpace is set to release its earnings on October 22, 2025, with an expected EPS of $3.5, representing a 16.28% increase year-over-year [2] - The consensus estimate for revenue is $640.45 million, indicating a 20.09% growth compared to the same quarter last year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates project earnings of $14.03 per share and revenue of $2.46 billion, reflecting increases of +11.08% and +16.86% respectively from the previous year [3] Analyst Revisions - Recent changes to analyst estimates for Medpace indicate a favorable outlook on the company's business health and profitability [3] - The Zacks Rank system, which incorporates these estimate changes, suggests potential stock price performance [4] Valuation Metrics - Medpace has a Forward P/E ratio of 36.65, which is a premium compared to the industry average Forward P/E of 17.34 [5] - The PEG ratio for Medpace is currently 3.23, compared to the average PEG ratio of 1.73 for the Medical Services industry [6] Industry Ranking - The Medical Services industry, which includes Medpace, has a Zacks Industry Rank of 96, placing it in the top 39% of over 250 industries [6][7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]